First line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients (MBC) presenting with de novo or recurrent disease

Authors
Publication date
1 January 2015
Publisher
place:2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Archivio istituzionale della ricerca - Università di Genova

    redirect
    oaioai:iris.unige.it:11567/935609
    Last time updated on 16/01/2019